Dr. Daniel M. Atienza, MD

Dr. Atienza practices at Virginia Oncology Associates in Suffolk, Virginia.

Dr. Atienza's NPI, 1912903279, was assigned on June 22, 2005. Dr. Atienza graduated from University of the East College of Medicine in 1983. Dr. Atienza holds Virginia license 0101054037.

Dr. Atienza's primary practice is Virginia Oncology Associates, at 5838 Harbour View Blvd, Suffolk, VA 23435 in Suffolk City. The practice phone is (757) 484-0215.

Dr. Atienza's primary practice is Virginia Oncology Associates in Suffolk, Virginia. Dr. Atienza is also affiliated with Sentara Obici Hospital. The medical group on file is Virginia Oncology Associates. Dmand AI also links Dr. Atienza to 4 more hospitals, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atienza practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Atienza's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Atienza is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Atienza's licenses on file in 6 states: Virginia, California, North Carolina, Texas, Maryland and Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Atienza treats.

CMS data shows 106,132 Medicare services from Dr. Atienza across 76 procedure codes in 2024, for 1,103 Medicare patients. Medicare paid $1,234,531 for them.

CMS counts 1,103 Medicare patients who saw Dr. Atienza in 2024. The largest group is 75 to 84, with 472 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Atienza's median patient age at 68, with 64% women.

In 2024, Dr. Atienza wrote 1,085 Medicare Part D claims for 236 patients. 78% of them were for generic drugs. CMS names the drug for 884 of them, across 30 drugs with 11 or more claims each, at $2,909,000 in total drug cost. In 2023, CMS named 583 claims across 19 drugs.

Dr. Atienza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Atienza as offering telehealth.

Dmand AI links 10 papers to Dr. Atienza, published from 2008 to 2022. The most frequent topics are Colonic Neoplasms, Chemotherapy, Adjuvant and Diet. Dr. Atienza has published most often in J Clin Oncol. Dr. Atienza's most frequent co-authors are Alan P. Venook, MD, Charles Stewart Fuchs, MD, MPH and Robert James Mayer, MD.

CMS Open Payments shows 40 general payments to Dr. Atienza from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Sanofi and Genzyme US Companies paid the most, $237.

Dr. Atienza graduated from University of the East College of Medicine in 1983. Dr. Atienza is a member of ACP and ASCO.

Dr. Atienza is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Molina. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.